This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
XtalPi has entered a strategic partnership with CK LifeSciences for artificial intelligence (AI)-driven tumour vaccine research and development (R&D). The aim of the alliance is to bring to market precision therapy for patients globally. In September 2020, the company raised funds worth $318.8m
The expansion will also contribute to building the province of Ontarios position as a global hub for lifesciences and biotechnology. The agency said it has also provided the company with site selection services, market intelligence and immigration support to streamline the investment process. million CAD ($11.2
Research from Everest Group shows how lifesciences leaders are investing in process mining to speed time-to-market, improve regulatory compliance and drive innovation.
This prestigious acknowledgment places Cloudbyz among the top-performing companies globally, known for delivering scalable and intuitive CTMS solutions that empower clinical research teams. Our mission is to enable faster, more efficient trials, ultimately supporting the delivery of life-saving therapies.”
by Nataliya Andreychuk, Co-founder and CEO of Viseven Many pharma brands still shy away from marketing directly to patients, depending on conversion through healthcare providers (HCPs). And it is not hard to see why.
In the lifesciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all lifesciences subsidiaries are located in the US. After all, around a third of the world’s leading lifesciences corporations have their headquarters in the country. Industry clusters.
This week, were celebrating a significant milestone: the release of our 200th episode of the Xtalks LifeScience Podcast ! We’re excited to continue our journey by bringing you more in-depth conversations with industry leaders, highlighting the innovations and trends that shape the future of lifesciences.
GSK has entered a strategic partnership with Wave LifeSciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. The discovery alliance, with a preliminary research period of four years, will aid GSK in progressing up to eight programmes and Wave to develop up to three programmes.
Consistency is a key factor in any successful lifescience content marketing strategy. By keeping the conversation going, content marketers within the lifescience industry can build trust with their audience and create a loyal following that will continue to engage with their content and products over time.
From the Human Genome Project to contemporary drug development, collaboration is critical to the lifesciences. It is also an important factor in the success of lifesciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.
It is no secret that Canada boasts a strong and competitive lifesciences sector. Within Canada, one province has often stood out as the place to be for cutting-edge lifesciences innovation. These factors have combined to make Ontario a leading force for medical research and innovation. Again, this is nothing new.
There is no doubt that business-to-business (B2B) lifescience webinars allow you to connect with potential and current customers in a very personal way. There are certainly a lot of benefits that can come with using this medium, so why not perfect your webinar marketing campaign with professional webinar production services?
Lifescience podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the lifescience industry. The result?
From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables lifesciences teams to collaborate efficiently and effectively in 2023. He is responsible for customer engagement, market adoption, and strategic alliances.
The future of lifesciences CRM will be defined by rapid digital transformation and a focus on customer experience – and those who stick to old ways of working will be left in the dust, according to new research from Gartner. From CRM to CXM.
As we step into 2024, the lifesciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinical trials.
The lifescience industry is constantly evolving, making it difficult to stay ahead of the curve. There’s no doubt that pharmaceutical and biotechnology organizations are utilizing innovative technology solutions across all sectors of drug development, research and development, supply chain, manufacturing and more.
Optum LifeSciences expert provides insights on the latest trends. For manufacturers developing GLP-1s or in the market, its invaluable to understand the nuances of how real-world evidence (RWE) can be harnessed to demonstrate the clinical and economic value of weight loss medications.
This Act is poised to significantly change the clinical trials landscape within the lifesciences sector. As AI increasingly becomes a cornerstone in clinical research and drug development, it is crucial for industry stakeholders to grasp the extensive implications of this regulation. first appeared on CLOUDBYZ.
WhizAI brings an augmented consumer platform to the lifesciences industry to deliver better, smarter and faster business decisions at lower TCO with contextual, AI-powered analytics. Last year, Gartner Research published a report titled “Top Trends in Data and Analytics for 2021: The Rise of the Augmented Consumer.”
Lifescience workers are one of the most common areas of work that could not eliminate all visits to the office or lab during the COVID-19 pandemic. Some scientists and researchers have been visiting their workplaces during the pandemic. So, what will work look like in the lifesciences as we emerge from the pandemic?
While several therapeutics are available for treating symptoms associated with epilepsy, researchers and patients have strongly called out the need for more holistic treatments that would address the condition as a whole. Meanwhile, others are researching the link between gene variation and different responses to treatments.
In the dynamic world of lifesciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its LifeSciences Cloud marks a significant stride towards this goal.
Recent research also found that, as of 2022, the sector had one of the lowest proportions of Net Zero targets of all industries. Two-thirds – 67% – of lifesciences companies surveyed had not set a Net Zero target in 2022. This should give the lifesciences sector the confidence to tackle the sustainability challenges it faces.
Established in 2018, CytoMed is a biotechnology firm that originated from the Agency for Science, Technology and Research (A*STAR), Singapore’s premier public sector research and development agency. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
In the early stages of drug development, it is logical to focus on the economic and clinical aspects of candidate identification: Is there enough of a market? This is an important effort, but as with any traditional marketresearch, it focuses on needs that the target audience has already identified.
Innovations in biotechnology are advancing the biopharmaceutical market, enabling the treatment of complex diseases with next-generation therapeutics synthesised or extracted from a biological source. With around 35,000 employees, the broader lifesciences sector is one of Hamilton’s largest industries.
The amount of money required to gain approval of a new drug has been hotly debated, but it also costs a hell of a lot of money to launch a drug in today’s market. A study in 2020 estimated that the median cost of getting a new drug into the market was $985 million, and the average price was $1.3 Only about $2.2 Only about $2.2
In June, the Association of the British Pharmaceutical Industry (ABPI) sent an open letter to the Conservative leadership, including Truss and Sunak, which warned that the UK is slipping behind its global competitors in the race to become a lifesciences superpower. UK clinical trials industry.
Successful, forward-thinking brands take a digital- and consumer-first approach to marketing across ages and populations. 90% want physician directories available on lifesciences and pharmaceutical sites. The post More bad research on pharma websites appeared first on World of DTC Marketing.com.
For the past year, lifescience companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. Despite the huge price difference, an emerging market company can generate the same revenue by tapping into their larger markets”.
Data is transforming lifesciences, but many organisations are not using its full potential. Lifesciences and the pharmaceutical industry are awash with data. Capturing market share. The combination of health and data, he passionately believes, will transform lifesciences. billion in 2021 to $9.23
As a strategic brand consultant at ramarketing, Laura combines her extensive background in clinical research with strategic leadership and creative expression.
Before the Covid-19 pandemic, government-led investment and engagement in lifesciences was relatively restricted worldwide, with the industry mostly funded via private investment. Many new therapeutics are needed to treat the broad range of bacterial infections, and bringing new antibiotics to market is both difficult and expensive.
In the fast-evolving field of clinical research, thought leaders do more than just keep up; they lead the charge and shape the direction of the industry. Heres how thought leaders are currently making an impact in clinical research: 1.
In 2022, lifesciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). Given the demand to deliver a steady stream of content to meet HCPs’ needs, pharma marketers must react, create, edit, and adapt quickly. And in 2023, these investments will hopefully pay off.
These strategic deals have reshaped the competitive landscape, spurred innovation and enabled companies to diversify their product offerings, expand into new markets and enhance operational efficiencies. The deal was valued at approximately $25 billion and strengthened Abbotts presence in the cardiovascular devices market.
Organisations are missing out on the ability to harness their data to energise precision marketing and transform commercial performance. The pharma industry is adjusting to massive upheaval from the pandemic and markets are emerging from its grip reshaped and alive with competition. Deeper Insights. Deeper Insights.
In the past, researchers have often had to seek help from outside the UK, thus delaying clinical trials and patient access. The NHSBT hopes the CBC will increase the UK’s competitiveness within the market. The opening of this new facility plays into the UK government’s LifeSciences Industrial Strategy.
Verista is a LifeSciences business, technology and compliance firm specializing in systems, quality, and validation solutions throughout the product lifecycle. The firm has a clear strategy of aggressively creating and expanding its organization to meet the ever-growing needs of an underserved market. The Verdict.
The UK’s health research data capabilities are rapidly evolving. For example, during the height of the pandemic, NIHR’s integrated health research system was able to compare COVID-19 hospital caseloads to COVID-19 research activity in real time. How this data can help with research planning, recruitment, and engagement.
In this interview, Craig Lipset, Co-Founder of the Decentralized Trials & Research Alliance, discusses the Alliance’s new glossary for industry and more. The global virtual clinical trials market is valued at $8.3 Today organizations have been stabilizing their approaches for decentralized research. percent to reach $12.9
Among these, mergers and acquisitions (M&As) have played a pivotal role in reshaping the industry landscape, enabling companies to bolster their portfolios, enhance R&D capabilities and expand their global market reach.
Let’s explore some of the innovative research and emerging trends shaping the epilepsy treatment landscape in this blog. Exploring Innovation in Epilepsy on Purple Day 2025 The progress seen in epilepsy research over recent years is nothing short of inspiring. Imaging and biomarker research are improving diagnostic precision.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content